Immuneering Corporation (IMRX) Net income 2020–2025
Immuneering Corporation (IMRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$56.0MFY2025 · since FY2020: -$17.0M → -$56.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$56.0M | +8.2% |
| FY2024 | -$61.0M | -14.1% |
| FY2023 | -$53.5M | -5.9% |
| FY2022 | -$50.5M | -50.6% |
| FY2021 | -$33.5M | -96.8% |
| FY2020 | -$17.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice